Prevention of Infection of the Vascular Access - General

Guideline Organization

Recommendation (Evidence Level)

Evidence

Comments

CARI-Australia

CSN-Canada
2006

- Staff and patients should be educated on infection control measures (Grade D-Opinion)

Guideline Chapter 4 – Managing VA Complications
pdf: Pg 18 of 27

EBPG-Europe
1999

VI.2
- All high risk patients (past history of S aureus or central vein catheters) should be screened for nasal colonization (Level B)
- Intervention to eradicate S aureus carriage to be considered in these high risk groups
VI.3.1 (Level B)
- Access should be a native fistula whenever possible (Level B)
VI.3.2.
- Good personal hygiene for patients (Level B)
- HD staff training mandatory (Level C)

Guideline VI.2 Prevention of infection:  management of host colonization by Staphylococcus aureus




Guidelines VI.3 Prevention of infection:  management of the vascular access

KDOQI-US
2001

Staff and patient education necessary for infection control (Opinion)

Guideline 13:  Infection control measures

UK-Guidelines
2002

- All units should have a documented infection control policy (Good practice)
- All dialysis patients are to be screened for S aureus nasal carriage every 3 months (Good practice)
- S aureus nasal carriers (Level A)
a) either intranasal 2% mupirocin cream
b) or eradication followed by long-term once-weekly application of 2% mupirocin

9. Blood-borne viruses and microbiology in the renal unit
P 157 of 204 PDF pages